Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, openWorldHint=true, idempotentHint=true, and destructiveHint=false, covering the safety profile. The description adds substantial behavioral context beyond that: it discloses the tool cascades through multiple lookup endpoints, that LEI/FIGI enrichment 'degrades gracefully' when GLEIF or OpenFIGI is unavailable, that unresolved identifiers are explicitly listed under 'unresolved' rather than omitted, and that ambiguity leads to returning figi_candidates. It also details the underlying data sources (SEC EDGAR, GLEIF, OpenFIGI, RxNorm) and the ISIN-to-LEI mapping for non-US issuers. This is far more than annotations provide and gives an agent a realistic model of how the tool behaves under various conditions. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is extremely long and structured as a single dense paragraph with embedded parentheticals and clauses. It starts with examples (helpful) but then piles on technical details about sources, fallback behavior, and ambiguity handling in a way that requires careful reading. While every sentence carries important information, the lack of bullet points or clear sections reduces scannability. It earns a 3 because it's informative but not concise; it could be split by entity type or behavior without losing value.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (two entity types, multiple underlying sources, fallback behavior, ambiguity handling, no output schema), the description covers all the essential aspects an agent needs to call it correctly: what input formats are accepted (ticker, CIK, ISIN, brand/generic name), what will be returned (CIK, ticker, LEI, FIGI, RxCUI, etc.), how ambiguity is resolved (figi_candidates), and what happens on degradation. It even warns about a specific pitfall (bond issuer naming). Since there is no output schema, the description must convey return semantics, and it does thoroughly. No critical gap is apparent.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Even though schema coverage is 100% (both properties have descriptions), the tool description adds critical semantic detail. For 'type', it explains the meaning of each enum value with concrete identifiers returned (e.g., company returns CIK, ticker, LEI, FIGI; drug returns RxCUI and ingredient). For 'value', it gives crucial input formatting guidance: 'Pass the ENTITY NAME ONLY' and warns that trailing security-class words like 'revenue bonds' will cause the lookup to fail. This goes well beyond the schema's basic description and directly prevents common misuse. The description also explains edge cases like interest-only bond identifiers and how an ISIN resolves via GLEIF. This is a 5 on parameter semantics.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete example queries ('What's the ticker for…', 'find the CIK for…') and then states the core function: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It explicitly frames itself as the tool to use when you have a name but need an ID, and it covers two entity types (company, drug) with specifics about what identifiers are produced. This distinguishes it from siblings like entity_profile (which likely provides broader entity information) and search (which finds documents), so the purpose is unambiguous and well-scoped.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit usage instruction: 'Use FIRST whenever you have a name but need an ID.' It also clarifies when not to expect a single answer (when a name matches multiple instruments it returns figi_candidates, 'which is the correct answer to an issuer name that does not identify a single bond'). It explains the tool replaces 2-3 manual lookups and provides examples of accepted inputs (ticker, CIK, ISIN, name). However, it does not explicitly contrast with sibling tools like entity_profile or search, so the 'when NOT to use' guidance is only implied (e.g., if you already have an ID, you likely don't need this). Thus it's strong but not perfect.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.4/5.0
Disambiguation2/5

Several tools are near-identical: ask_pipeworx and ask_pipeworx_beta are explicitly the same function, ask_pipeworx_grounded is the same router with a different response mode, and polymarket_edges/polymarket_arbitrage/polymarket_edge_tracker/polymarket_fill_risk all overlap on prediction-market edge detection. search vs search_within vs discover_tools also blur discovery boundaries. An agent would struggle to pick the right tool without reading every long description.

Naming Consistency3/5

All names are snake_case and individually readable, so there's no chaotic style mixing. However, the pattern is inconsistent: bare verbs (search, recall, forget, subscribe), verb_noun (get_package, resolve_entity, scan_dependency), noun phrases (latest_version, recent_alerts), and compound prefixes (pipeworx_*, polymarket_*). The server is named 'Nuget' but the vast majority of tools carry pipeworx_ or polymarket_ prefixes, making the namespace feel like a grab-bag.

Tool Count2/5

35 tools is far too many for a server ostensibly named 'Nuget' — only ~5 tools relate to NuGet package lookup (search, get_package, list_versions, latest_version, scan_dependency), and even scan_dependency is npm-only. The remaining ~30 tools belong to an unrelated Pipeworx research/markets/memory platform. The count is inflated by redundant variants (ask_pipeworx trio, six polymarket tools) rather than distinct functionality.

Completeness2/5

Judged by the server's stated purpose (NuGet), the surface is thin and has dead ends: search and version metadata are covered, but there's no package owner/publisher info, no readme/description body fetch, no download stats beyond totals, and scan_dependency targets the wrong ecosystem (npm). Judged by the actual dominant domain (Pipeworx), coverage is excessive and sprawling. The tool set fails to deliver a coherent, complete surface for either apparent purpose.